We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / Products & Services / Pharmaceuticals / 3 facts about Antibody Drug Conjugates (ADCs)
3 facts about Antibody Drug Conjugates (ADCs)
Pharmaceuticals

3 facts about Antibody Drug Conjugates (ADCs)


Novasep 3 Facts About ADCs

ADCs are innovative therabees

1. A new class of biopharmaceutical drugs used to treat cancer

2. A more precise anti-tumor targeting 

3. A stronger therapeutic effectiveness

4. A better quality of life for patients

 

They are composed of 3 elements

          mAb (Monoclonal AntiBody): Specific protein that recognizes and targets cancer cells

          Payload: Highly active ingredient that kills cancer cells

          Linker: Small molecule that connects the cytotoxic payload to the mAb

 

ADCs have potent perspectives

11 ADCs launched

96 ADCs in active clinical development

 

Do you want to learn more? 
Discover our FAQ

Downloads
  • Case study: 1st ADC lead candidates to support pre-tox development program
    Case study: 1st ADC lead candidates to support pre-tox development program
    Novasep was approached by a biopharmaceutical company developing a preclinical ADC consisting of IgG...
    Download +
  • Case study: ADC payload process development and manufacturing
    Case study: ADC payload process development and manufacturing
    Novasep was approached by a top 10 pharmaceutical company looking for a reliable partner to manufact...
    Download +
  • ADC Bioconjugation: development and cGMP manufacturing of a candidate for Phase I clinical trials
    ADC Bioconjugation: development and cGMP manufacturing of a candidate for Phase I clinical trials
    Discover how we supported one of our clients with the cGMP bioconjugation of an ADC for Phase I clin...
    Download +
  • A full range of CDMO services for ADCs
    A full range of CDMO services for ADCs
    Find out the solution adapted to your needs with Novasep's fully integrated CDMO services for ADCs
    Download +
  • Report: PBD-Dimer Payloads for Antibody Drug Conjugates
    Report: PBD-Dimer Payloads for Antibody Drug Conjugates
    From the 1960s when monomeric PBDs such as anthramycin were isolated and characterized, to the drama...
    Download +
  • Case study: Advanced Antibody Drug Conjugate characterization
    Case study: Advanced Antibody Drug Conjugate characterization
    Discover the internal platform method for fast ADC characterization, developed by Novasep's QC exper...
    Download +
Contact

A question ? A request ? Leave us a message !

Contact us
You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Your brochure is ready!

X

You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Give us your feedback!